KROS
#4978
Keros Therapeutics, Inc. - common stock
0.1 1 USD
-99.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-99.01%
Monthly Change
-98.98%
6 month change
-99.35%
Year Change
-99.25%
Previous Close
11.3 9
Open
0.1 1
Low
0.1 1
High
0.1 1
Volume
43
Financials
- Market Capitalization 2.23 M
- Employee 87
- Founded 2015
- CEO N/A
- Website www.kerostx.com
- Headquarter Massachusetts, United States
- FIGI BBG00H1HP9G9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
8.85
Price to sales ratio
3.16